Ozempic and Wegovy are being linked to surprising effects on overall health. A new study finds these drugs may improve heart health, reduce infections, lower substance abuse risks, and even decrease the chance of dementia.

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, addiction, heart disease, and gastrointestinal problems, among others.

A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what to know, per a neurologist.

GLP-1 medications like Ozempic, Wegovy, and Mounjaro are linked to reduced risks of dementia, heart failure, and severe infections, according to a study involving over 2 million patients. However, these weight-loss and diabetes drugs also pose risks,

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease and psychotic disorders.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cancer and dementia,

Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Tuesday in the journal Alzheimer's and Dementia: Translational Research & Clinical Interventions .

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes,

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing them as miracle drugs.

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.

By Melissa Patrick and Liberty Gilbert Kentucky Health News Whether it is prescribed for diabetes or weight loss, Ozempic and other weight loss drugs have found their home in Kentucky, even though researchers from Washington University in St.